Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$439,111
+$81,123 QoQ
Shares Held
1,745
+6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3,289
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GW HENSSLER & ASSOCIATES LTD holds $66,383,683 across 9 Drug Manufacturers - General names. ABBV ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
179,384 | $23,050,844 | |
| 2 | AMGN |
Amgen Inc
|
56,900 | $20,604,628 | |
| 3 | NVS |
Novartis AG
|
123,971 | $19,428,735 | |
| 4 | LLY |
ELI LILLY & Co
|
1,085 | $1,301,381 | |
| 5 | JNJ |
Johnson & Johnson
|
2,465 | $626,036 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
1,745 | $439,111 | |
| 7 | NVO |
Novo Nordisk A S
|
7,450 | $357,153 | |
| 8 | PFE |
Pfizer Inc
|
13,763 | $331,413 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $439,111 | 1,745 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $357,988 | 1,646 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $366,954 | 1,606 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $371,853 | 1,606 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $532,543 | 2,869 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $638,616 | 3,048 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $219,281 | 1,234 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $255,736 | 1,295 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $358,648 | 2,091 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $29,886,798 | 164,123 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $25,851,940 | 166,819 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $25,222,442 | 169,210 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $23,064,698 | 171,192 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $27,395,703 | 171,900 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $28,195,450 | 174,466 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $23,547,010 | 175,449 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $26,769,457 | 174,781 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $28,523,416 | 175,951 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $23,710,435 | 175,114 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $18,797,318 | 174,259 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $19,411,025 | 172,328 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $18,353,029 | 169,590 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $17,474,557 | 163,085 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $14,409,343 | 164,509 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $15,811,005 | 161,041 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $11,115,816 | 145,896 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||